Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Feb;14(1):58-62.
doi: 10.1097/MED.0b013e328012d605.

Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implications

Affiliations
Review

Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implications

Joseph R Pisegna et al. Curr Opin Endocrinol Diabetes Obes. 2007 Feb.

Abstract

Purpose of review: The purpose of this review is to highlight the importance of pituitary adenylate cyclase-activating polypeptide in physiological processes and to describe how this peptide is becoming increasingly recognized as having a major role in the body. Since its discovery in 1989, investigators have sought to determine the site of biological activity and the function of pituitary adenylate cyclase-activating polypeptide in maintaining homeostasis.

Recent findings: Since its discovery, pituitary adenylate cyclase-activating polypeptide appears to play an important role in the regulation of processes within the central nervous system and gastrointestinal tract, as well in reproductive biology. Pituitary adenylate cyclase-activating polypeptide has been shown to regulate tumor cell growth and to regulate immune function through its effects on T lympocytes. These discoveries suggest the importance of pituitary adenylate cyclase-activating polypeptide in neuronal development, neuronal function, gastrointestinal tract function and reproduction.

Summary: Future studies will examine more closely the role of pituitary adenylate cyclase-activating polypeptide in regulation of malignantly transformed cells, as well as in regulation of immune function.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Amino acid model and partial gene structure of the human pituitary adenylate cyclase-activating polypeptide receptor (hPACAP-R)
(a) Model of the predicted amino acid sequence for the hPACAP-R gene showing seven transmembrane-spanning regions (boxed amino acids), potential sites for N-linked glycosylation (tridents), signal peptide cleavage site, seven highly conserved cysteine residues (triangles), and the nonhomologous rPACAP-R amino acids (letters outside the circles). Amino acid products of the alternatively spliced exons, SV-1 and SV-2, are shown in brackets with their location in the third intracellular loop indicated by the arrow. (b) Model of the partial gene structure of the hPACAP-R gene showing the consensus sequences for the intron–exon splice sites for the exons SV-1 and SV-2. Two consecutive splice sites for the SV-2 exon (a and b) give rise to two possible splice variants (SV-2a and SV-2b). Modified from [10].

Similar articles

Cited by

References

    1. Miyata A, Arimura A, Dahl RR, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164:567–574. - PubMed
    1. Vaudry D, Gonzalez BJ, Basille M, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 2000; 52:269–324. - PubMed
    1. Arimura A Pituitary adenylate cyclase-activating polypeptide (PACAP): discovery and status of current research. Reg Peptides 1992; 37:287–303. - PubMed
    1. Koves K, Arimura A, Gorcs TG, Somogyvari-Vigh A. Comparative distribution of immunoreactive pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology 1991; 54:159–169. - PubMed
    1. Zeng N, Kang T, Wong H, et al. PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J Clin Invest 1999; 104:1383–1391. - PMC - PubMed

MeSH terms

Substances